1Marian GM. Treatment of congential cytomegalovirus: where are we now [ J ]. Expert Rev Anti Infect Ther,2007,5 ( 3 ) :441-448.
2Nigro G, Anceschi MM, Cosmi EV. Clinical manifestations and abnormal laboratory findings in pregnant women with primary cytomegalovirus infection[ J ]. BJOG ,2003,110:572-277.
3Adler SP, Finney JW, Manganello AM, et al. Prevention of child-to-mother transmission of cytomegalovirus among pregnant women [ J]. J Pediatr,2004,145:485-491.
4Vincenzo Berghella. Maternal-fetal Evidence Based Guildelines [ M ]. New York : lnforma Heahhcare,2007:297.
5Nigro G, Adler SP, La Torre R, et al. Passive immunization during pregnancy for congenital cytomegalovirus infection [ J ]. N Engl J Med ,2005,353 : 1350-1362.
6Rotarian E, Zamir CS, Rilkis I, et al. Congenital toxoplasmosisprenatal aspects of Toxoplasma gondii infection[ J ]. Reprod Toxicol ,2006,21:458-472.
7Tang JW, Aarons E, Hesketh LM, et al. Prenatal diagnosis of congenital rubella infection in the second trimester of pregnancy[ J]. Prenat Diagn ,2003,23 ( 6 ) :509-512.
8Mace M, Cointe D, Six C, et al. Diagnostic value of reverse transcription-PCR of amniotic fluid for prenatal diagnosis of congenital rubella infection in pregnant women with conflrrsed primary rubella infection [ J ]. J Clin Micribiol, 2004, 42 ( 10 ) : 4818- 4820.
3Gibson CS, MacLennan AH, Goldwater PN, et al. Neurotropic vi- ruses and cerebral palsy: population based case -control study[ J]. BMJ, 2006, 332(7533): 76.
